Skip to main content

Featured

BUSINESS GOVirtual Expo & Conference 2022

BUSINESS GOVirtual Expo & Conference (BUSINESS GOVirtual), the Hong Kong's first physical B2B "Tech x Business" event in the post-pandemic period, gathers leading IT companies and solutions providers under one roof to demonstrate their latest technologies. It is also the platform where showcases the key technological advancements for social and business engagement in the new digital era. The development of the Greater Bay Area is accorded the status of critical strategic planning in the Chinese government's blueprint, with great significance in China's initiative on innovation-driven development. Strategically held in Hong Kong, the international innovation and technology hub, BUSINESS GOVirtual serves as a communication platform for tech companies to exchange ideas, collaborate and foster partnerships. On top of the physical event, the brand new "GOVirtual OMNI," an online platform for the Expo and Conference, welcomes regional exhibitors and visito

Vaccination cases assessed

The Expert Committee on Clinical Events Assessment Following COVID-19 Immunisation assessed three death cases with history of vaccination during its meeting today.       As of April 4, the Department of Health received a total of 15 death reports with history of COVID-19 immunisation from the Hospital Authority.   The cases involve 11 men and four women aged between 55 and 80. Existing information indicates that most of these cases died of cardiovascular diseases.   Three of the cases were assessed in today's meeting.   The first case involves a 67-year-old man who passed away on March 13. The full autopsy report indicated that the patient died of acute myocardial infarction due to coronary atherosclerosis, while other investigations did not reveal possible immunological reactions due to a vaccine.   The committee considered that there was no causal relationship between the deceased's outcome and COVID-19 vaccination.   The second case involves a 68-year-old woman with hypertension, hypothyroidism and lipid disorder who passed away on March 29 and received a dose of CoronaVac 26 days before her death.   Based on the preliminary autopsy findings of acute myocardial infarction, the committee considered that the deceased's outcome was not directly associated with COVID-19 vaccination.   The last case involves a 62-year-old man with a history of newly diagnosed hypertension who passed away on April 2 and received a dose of CoronaVac 25 days prior to his death. The causality assessment will be conducted when preliminary autopsy findings are available.
http://dlvr.it/RxBS5n

Popular Posts